DOCFLiX.site
Subscribe
general

Lingering distrust, low vaccine rates threaten containment of Lancaster measles outbreak - Pittsburgh Post-Gazette

Pittsburgh Post-Gazette·28 June 2026 at 18:29·1 min read
← Headlines/general
Summary

False

Image source: Pittsburgh Post-Gazette

Source
Pittsburgh Post-Gazette
Category
general
Published
28 June 2026 at 18:29
Why This Matters

This story was curated by DOCFLiX.site from Pittsburgh Post-Gazette as part of our daily briefing service. We select and present the most significant developments across Business, Technology, and Crime Scene to keep our readers informed with source-verified, primary-cited news coverage. The summary above is derived from the original reporting by Pittsburgh Post-Gazette.

Read Full Story on Pittsburgh Post-Gazette →← Back to Headlines
Related Investigations
From DOCFLiX.site
TikTok's Algorithm Patent: What ByteDance Actually Filed in Beijing
Technology

TikTok's Algorithm Patent: What ByteDance Actually Filed in Beijing

The 2023 Chinese patent filing CN116188141A describes a recommendation engine optimised for 'national strategic engagement goals.' We parse the technical language — and what it means for Western users.

The Surveillance Dividend: How 14 U.S. Cities Are Using Amazon Rekognition Data
Technology

The Surveillance Dividend: How 14 U.S. Cities Are Using Amazon Rekognition Data

FOIA requests from 14 municipalities reveal the scope of face-recognition contracts signed with AWS since 2019 — and the contractual clauses that prevent public disclosure.

Apple's CSAM Detection Failure: The NeuralHash Post-Mortem and What Comes Next
Technology

Apple's CSAM Detection Failure: The NeuralHash Post-Mortem and What Comes Next

Three years after Apple quietly shelved its NeuralHash CSAM detection system, previously unreported NCMEC agreements, UK Online Safety Act compliance pressures, and internal engineering post-mortems reveal the complete story of why the system failed — and what Apple must build next.

✦ Stay Informed

New Investigations.
Every Month. Free.

Get every new investigation delivered to your inbox — fully source-cited, no paywalls, reader-supported. Join 2,400+ readers already subscribed.

Subscribe Free
f FacebookInstagram